Clinical Trials Directory

Trials / Completed

CompletedNCT03969303

NOTAL-OCT V.2.5 vs Commercial OCT in AMD Patients

Comparison Between Retinal Images Captured by NOTAL-OCT V2.5 and Zeiss Cirrus / Heidelberg Spectralis SD OCT - Study Protocol

Status
Completed
Phase
Study type
Observational
Enrollment
287 (actual)
Sponsor
Notal Vision Ltd. · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Primary objective: To evaluate the level of agreement between the NOTAL-OCT V2.5 and a commercial OCT in the presence of fluid as identified in the OCT images, in the central 10 degrees of the macula in AMD (Age-related Macular Degeneration) patients. Secondary objectives: 1. To evaluate the level of agreement between the NOTAL-OCT V2.5 and a commercial OCT in the presence of fluid as identified in the OCT images, in the central 10 degrees of the macula in DME (Diabetic Macular Edema) patients. 2. To evaluate patient experience when self-operating the Notal-OCT V2.5.

Detailed description

To evaluate the sensitivity and specificity regarding the presence and absence of fluid on OCT images of AMD patients. OCT images from the central 10 degrees of the macula in AMD patients will be obtained using the NOTAL OCT v.2.5 and a commercial OCT device (Zeiss Cirrus / Heidlberg SPECTRALIS). These images will be evaluated for the presence/absence of fluid in the images by a human grader. The sensitivity and specificity will be determined by comparison of the presence/absence of fluid in the NOTAL OCT v2.5 images with the presence/absence of fluid in the commercial OCT images. To evaluate the sensitivity and specificity regarding the presence and absence of fluid on OCT images of DME patients. OCT images from the central 10 degrees of the macula in DME patients will be obtained using the NOTAL OCT v.2.5 and a commercial OCT device (Zeiss Cirrus / Heidlberg SPECTRALIS). These images will be evaluated for the presence/absence of fluid in the images by a human grader. The sensitivity and specificity will be determined by comparison of the presence/absence of fluid in the NOTAL OCT v2.5 images with the presence/absence of fluid in the commercial OCT images. Patients will complete a questionnaire regarding the usability of the NOTAL-OCT v.2.5 device

Conditions

Interventions

TypeNameDescription
DEVICENotal Vision Optical Coherence Tomography Device Version 2.5 (NOTAL-OCT V2.5)OCT SCAN

Timeline

Start date
2018-10-20
Primary completion
2019-07-11
Completion
2019-10-04
First posted
2019-05-31
Last updated
2020-11-12

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03969303. Inclusion in this directory is not an endorsement.